JIJosef Isung

Josef Isung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Josef Isung has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • David Mataix-Cols

    Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden

    5 shared publications
  • Kayoko Isomura

    Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

    4 shared publications
  • Lorena Fernández de la Cruz

    Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet and Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden

    4 shared publications
  • Anna Sidorchuk

    Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

    3 shared publications
  • Henrik Larsson

    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

    3 shared publications
  • Kyle Williams

    Department of Psychiatry, Massachusetts General Hospital, Boston

    2 shared publications

Latest Publications

  • Open Access

    Obsessional jealousy: Provisional research criteria and report of 34 cases

    by David Mataix-Cols, Josef Isung, Anna Norberg, Sigrid Elfström, Johanna Linde, Johan Bjureberg, Long-Long Chen, Johan Åhlén

    Background: Obsessional jealousy is described in DSM-5 under Other Specified Obsessive-Compulsive and Related Disorders, yet operationalized criteria and clinical characterization are lacking. This study aimed to develop and field-test provisional research criteria for obsessional jealousy and describe the clinical features of individuals meeting these criteria. Methods: Provisional research criteria were developed based on DSM-5 descriptions and applied in a self-referred sample of individuals reporting problematic jealousy ( n = 58). Participants underwent structured clinical assessment, including best-estimate diagnostic procedures, evaluation of differential diagnoses, and measures of functional impairment. Participants’ views on introducing a formal jealousy diagnosis were explored. Results: Among the participants, 34 (59%) met the provisional research criteria. The criteria showed strong sensitivity but modest specificity, reflecting a deliberately conservative threshold to avoid over-pathologization. All individuals meeting criteria were judged to meet DSM-5 and ICD-11 definitions of mental disorder. Obsessional jealousy was typically recurrent across relationships, with onset in mid-adolescence and clinical significance emerging in early adulthood. Participants showed generally good insight; comorbidity was common with mood and anxiety disorders. Many reported prior help-seeking and ongoing need for treatment. Participants expressed balanced views regarding formal diagnosis, citing both potential benefits and risks. Conclusions: These findings identify a group of individuals with pervasive, recurrent obsessional jealousy that is distressing, impairing, and not readily explained by existing diagnostic categories. The proposed criteria provide an initial framework for research and clinical development but require further refinement and validation in more representative community and clinical samples, with careful attention to diagnostic boundaries, transcultural aspects, and stakeholder perspectives.

  • Open Access

    Patterns and treatment of sexual dysfunction in major depressive disorder: A cohort and case-control study in Sweden

    by Josef Isung, Pär Karlsson, Onur Tankaya, Viktoria Johansson, Karin Gembert, Johan Reutfors


  • Innovation in treating obsessive-compulsive disorder will not solve the care gap

    by Josef Isung, Lorena Fernández de la Cruz, David Mataix-Cols

    Inadequate trials hinder translation into effective treatments

  • Open Access

    Association of Primary Immunodeficiencies in Parents With Psychiatric Disorders and Suicidal Behavior in Their Offspring

    by Josef Isung, Kayoko Isomura, Kyle Williams, Tianyang Zhang, Paul Lichtenstein, Lorena Fernández de la Cruz, Anna Sidorchuk, David Mataix-Cols

    Importance: Maternal immune activation (MIA) leading to altered neurodevelopment in utero is a hypothesized risk factor for psychiatric outcomes in offspring. Primary antibody immunodeficiencies (PIDs) constitute a unique natural experiment to test the MIA hypothesis of mental disorders.Objective: To assess the association of maternal and paternal PIDs with psychiatric disorders and suicidal behavior in offspring.Design, Setting, and Participants: Cohort study of 4 294 169 offspring of parents with and without PIDs living in Sweden at any time between 1973 and 2013. Data were extracted from Swedish nationwide health and administrative registers and were analyzed from May 5 to September 30, 2022. All individuals with diagnoses of PIDs identified between 1973 and 2013 from the National Patient Register were included. Offspring were included if born before 2003. Parent-offspring pairs in which both parents had a history of PIDs were excluded.Exposures: Lifetime records of parental PIDs according to the International Classification of Diseases, Eighth Revision (ICD-8); International Classification of Diseases, Ninth Revision (ICD-9); and International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) diagnostic codes.Main Outcomes and Measures: Lifetime records of 10 psychiatric disorders and suicidal behavior identified using ICD-8, ICD-9, and ICD-10 diagnostic codes, including suicide attempts and death by suicide, among offspring. Covariates included sex, birth year, parental psychopathology, suicide attempts, and autoimmune diseases. Additional analyses excluded offspring with their own PIDs and autoimmune diseases. Poisson regression models were fitted separately for mothers and fathers to estimate incidence rate ratios (IRRs) and 95% CIs for the risk of psychiatric and suicidal behavior outcomes in the offspring of PID-exposed vs PID-unexposed mothers or fathers.Results: The cohort included 4 294 169 offspring (2 207 651 males [51.4%]) and 3 954 937 parents (1 987 972 females [50.3%]). A total of 7270 offspring (0.17%) had parents with PIDs, and 4 286 899 offspring had parents without PIDs. In fully adjusted models, offspring of mothers with PIDs had an increased risk of any psychiatric disorder, while no such risks were observed in offspring of fathers with PIDs (IRR, 1.17; 95% CI, 1.10-1.25 vs IRR, 1.03; 95% CI, 0.94-1.14; P < .001). Likewise, an increased risk of suicidal behavior was observed among offspring of mothers with PIDs but not offspring of fathers with PIDs (IRR, 1.20; 95% CI, 1.06-1.36 vs IRR, 1.10; 95% CI, 0.91-1.34; P = .01). For the offspring of mothers with PIDs, the risk of developing any psychiatric disorder was significantly higher for those with mothers with 6 of 10 individual disorders, with IRRs ranging from 1.15 (95% CI, 1.04-1.26) for anxiety and stress-related disorders and 1.15 (95% CI, 1.03-1.30) for substance use disorders to 1.71 (95% CI, 1.37-2.14) for bipolar disorders. Offspring of mothers with both PIDs and autoimmune diseases had the highest risk for any psychiatric disorder (IRR, 1.24; 95% CI, 1.11-1.38) and suicidal behavior (IRR, 1.44; 95% CI, 1.17-1.78).Conclusions and Relevance: Findings of this cohort study suggest that maternal, but not paternal, PIDs were associated with a statistically significant increased risk of psychiatric disorders and suicidal behavior in the offspring, particularly when PIDs co-occur with autoimmune diseases. These findings align with the MIA hypothesis of mental disorders, but the precise mechanisms remain to be elucidated.


  • Open Access

    Association of Tourette Syndrome and Chronic Tic Disorder With Cervical Spine Disorders and Related Neurological Complications

    by Josef Isung, Kayoko Isomura, Henrik Larsson, Anna Sidorchuk, Lorena Fernández de la Cruz, David Mataix-Cols

    Tourette syndrome (TS) and chronic tic disorder (CTD) are neurodevelopmental disorders with a typical onset during early childhood.1 The cardinal symptoms are sudden, rapid, nonrhythmic movements, and/or sounds referred to as motor and vocal tics, respectively.1 Motor tics can be simple, involving a single muscle group, or complex, involving several muscle groups and more elaborate movements.1 Motor tics involving the neck region (eg, neck stretches/movements, head jerk movements, complex head/shoulder/neck movements) are common, occurring in up to 58% of children and adults with TS/CTD2 and also are reported to be among the most bothersome tics.3 The neck is particularly vulnerable to severe damage owing to repeated trauma.4 Single case reports5-11 and a case series4 of individuals with severe motor tics involving the head and neck region have described a range of severe injuries to the cervical spine with neurological complications. These include cervical disc herniation, cervical myelopathy with neurological complications, and even stroke secondary to traumatic vascular dissection of the carotid and vertebral arteries. Injury to the cervical cord following severe tics may require surgical interventions, such as removal of spinal elements for decompression (Figure 1), as well as highly specialized interventions such as deep brain stimulation to prevent further damage.12 Whether these anecdotal reports represent isolated cases or a more common phenomenon among individuals with TS/CTD is unknown. Given the potential seriousness of cervical spine disorders, it would be important to establish the prevalence and nature of cervical spine disorders in individuals with TS/CTD; this would help raise awareness and improve vigilance of individuals in need of individually tailored interventions to prevent long-term disability.


  • Open Access

    Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis

    by Peter Sjöstedt, Jesper Enander, Josef Isung

    The monoamine hypothesis of psychopharmacology has been dominating the biological psychiatric research field for decades. Currently psychiatric research has increasingly appreciated psychiatric disorders and suicidal behavior as being highly complex and multi-etiological. In this pathway the gut microbiome and its interrelationship with the brain is gaining traction. The usage of selective serotonin reuptake inhibitors (SSRIs) is increasing in the general population. This is due to their effect on a broad range of psychiatric disorders, and their favorable side effect profile. Still, there are enigmatic aspects about SSRIs, such as the difficulty to predict effect in individual patients, inter-individual differences in side effect, tachyphylaxis (a sudden loss of response to a certain drug), and to date, uncertainties on how they exert their clinical effect. A majority of the serotonin in the human body is produced within the gut, and SSRIs affect enteric neurons. They also exhibit antimicrobial properties that comes with the potential of disrupting microbial hemostasis. We propose that the role of the gut-brain axis and the gut microbiome in relation to psychopharmacology should be more highlighted. With this article, together with similar articles, we would like to provide a hypothetical framework for future studies within this field. We believe that this would have the potential to provide a paradigm shift within the field of psychopharmacology, and result in findings that potentially could contribute to the development of a more personalized and tailored treatment.


  • Open Access

    Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects

    by Josef Isung, Mathias Granqvist, Ada Trepci, Jesse Huang, Lilly Schwieler, Marie Kierkegaard, Sophie Erhardt, Jussi Jokinen, Fredrik Piehl

    Mounting evidence shows that physical exercise modulates systemic inflammation. However, its effect on cerebrospinal fluid (CSF) immune-marker profiles in man are largely unknown. We here report a study on healthy subjects (n = 27, males = 12, mean age 28.7, range 22–52) allocated to either an acute exercise setting over four consecutive days, or a training intervention over 4 weeks. Paired plasma and CSF samples collected at baseline, after 7 days of exercise abstention, and the day after completion of the exercise interventions, were analyzed for protein inflammation markers using a multiplex proximity extension assay and neurotransmitters and kynurenine pathway (KP) metabolites using liquid chromatography, respectively. Routine cell counts, and albumin, immunoglobulin G and neurofilament light chain concentrations in CSF remained unchanged in both paradigms, while several inflammatory proteins became upregulated after acute exercise. However, only changes in three CSF (vascular endothelial growth factor-A, interleukin-7 and matrix metalloproteinase-10) and 12 plasma proteins reached significance levels after adjustment for multiple comparisons and exclusion of less stable proteins. Similarly, KP metabolites only changed among participants after acute exercise, while neurotransmitter levels, except for increased CSF serine, remained stable. Both in plasma and CSF changes in KP metabolites and inflammatory proteins correlated, suggesting that these processes are functionally linked. These findings suggest that acute aerobic physical exercise affects immune markers and KP metabolites systemically and in the CSF.


  • Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior and the Role of Autoimmune Diseases

    by Josef Isung, Kyle Williams, Kayoko Isomura, Caroline Gromark, Eva Hesselmark, Paul Lichtenstein, Henrik Larsson, Lorena Fernández de la Cruz, Anna Sidorchuk, David Mataix-Cols

    Mounting evidence suggests that immune disruption may be etiologically important in psychiatric disorders through a range of mechanisms, such as altered neurodevelopment, postinfectious priming of microglia, or microbial dysbiosis.1-3 However, little is known about the neuropsychiatric consequences resulting from the underproduction of homeostatic antibodies. Thus, primary humoral immunodeficiencies (PIDs)4 could provide an interesting model to disentangle the effects of humoral immunodeficiency and autoimmune diseases on psychiatric disorders.


  • Open Access

    Improvement in indices of cellular protection after psychological treatment for social anxiety disorder

    by Kristoffer N. T. Månsson, Daniel Lindqvist, Liu L. Yang, Cecilia Svanborg, Josef Isung, Gustav Nilsonne, Lise Bergman-Nordgren, Samir El Alaoui, Erik Hedman-Lagerlöf, Martin Kraepelien, et al.

    Telomere attrition is a hallmark of cellular aging and shorter telomeres have been reported in mood and anxiety disorders. Telomere shortening is counteracted by the enzyme telomerase and cellular protection is also provided by the antioxidant enzyme glutathione peroxidase (GPx). Here, telomerase, GPx, and telomeres were investigated in 46 social anxiety disorder (SAD) patients in a within-subject design with repeated measures before and after cognitive behavioral therapy. Treatment outcome was assessed by the Liebowitz Social Anxiety Scale (self-report), administered three times before treatment to control for time and regression artifacts, and posttreatment. Venipunctures were performed twice before treatment, separated by 9 weeks, and once posttreatment. Telomerase activity and telomere length were measured in peripheral blood mononuclear cells and GPx activity in plasma. All patients contributed with complete data. Results showed that social anxiety symptom severity was significantly reduced from pretreatment to posttreatment (Cohen’sd = 1.46). There were no significant alterations in telomeres or cellular protection markers before treatment onset. Telomere length and telomerase activity did not change significantly after treatment, but an increase in telomerase over treatment was associated with reduced social anxiety. Also, lower pretreatment telomerase activity predicted subsequent symptom improvement. GPx activity increased significantly during treatment, and increases were significantly associated with symptom improvement. The relationships between symptom improvement and putative protective enzymes remained significant also after controlling for body mass index, sex, duration of SAD, smoking, concurrent psychotropic medication, and the proportion of lymphocytes to monocytes. Thus, indices of cellular protection may be involved in the therapeutic mechanisms of psychological treatment for anxiety.


  • Open Access

    Association of chronic and acute inflammation of the mucosa-associated lymphoid tissue with psychiatric disorders and suicidal behavior

    by Josef Isung, Kayoko Isomura, Catarina Almqvist, Paul Lichtenstein, Henrik Larsson, Tomas Wester, Christian Rück, Lorena Fernández de la Cruz, Anna Sidorchuk, David Mataix-Cols

    Immune dysregulation due to chronic inflammation is a hypothesized risk factor underlying psychiatric disorders and suicidal behavior. Whether tonsillectomy and acute appendicitis used, respectively, as proxies for chronic and acute inflammation within the mucosa-associated lymphoid tissue (MALT) are associated with psychiatric disorders and suicidal behavior is currently unknown. A birth cohort study was conducted including 3,052,875 individuals born in Sweden between 1973 and 2003. We identified 210,686 individuals ever exposed to tonsillectomy and 86,928 individuals ever exposed to acute appendicitis, as well as 317,214 clusters of siblings discordant for tonsillectomy, and 160,079 sibling clusters discordant for acute appendicitis. Outcomes were an aggregate risk of ‘any psychiatric disorder’, ‘any suicidal behavior’, 12 individual psychiatric disorders, suicide attempts and deaths by suicide. Tonsillectomy was associated with increased odds of ‘any psychiatric disorder’ (adjusted odds ratio [aOR] = 1.39; 95% confidence interval (CI) = 1.38–1.41) and ‘any suicidal behavior’ (aOR = 1.41; 95% CI = 1.37–1.44), and most individual disorders. Acute appendicitis also increased the odds of ‘any psychiatric disorder’ and ‘any suicidal behavior’ (aOR = 1.23; 95% CI = 1.20–1.25, and aOR = 1.32; 95% CI = 1.28–1.37, respectively). Exposure to both tonsillectomy and appendicitis was associated with the highest odds of ‘any psychiatric disorder’ (aOR = 1.70; 95% CI = 1.59–1.82) and ‘any suicidal behavior’ (aOR = 1.90; 95% CI = 1.70–2.12). In sibling comparisons, the associations were attenuated but remained significant. We conclude that inflammation within the MALT, particularly when chronic, is robustly associated with a broad range of psychiatric disorders and suicidal behavior.